Translating Knowledge of IL-23 Targeting into New Solutions for Psoriasis Treatment - European...
Professor Marc Radtke The last decade has been one of the most exciting for dermatologists managing patients with psoriasis, and this has been largely due to the significant progress of targeted treatments. The key question is how to exploit these achievements to minimise the disease burden on individuals and society.